Kuros Biosciences AG Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Apr '25 Apr 10, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	623	806	128	54	63	66	Upgrade
Market Cap Growth	944.82%	528.00%	138.81%	-14.90%	-4.70%	20.42%	Upgrade
Enterprise Value	606	793	114	34	38	54	Upgrade
Last Close Price	16.40	21.35	3.49	1.47	1.93	2.02	Upgrade
PS Ratio	8.07	10.66	3.82	2.99	4.57	16.40	Upgrade
PB Ratio	10.57	13.71	2.26	0.78	0.82	0.78	Upgrade
P/TBV Ratio	25.59	33.12	8.15	2.67	3.01	2.45	Upgrade
P/FCF Ratio	304.43	393.96	-	-	-	-	Upgrade
P/OCF Ratio	256.57	256.57	-	-	-	-	Upgrade
EV/Sales Ratio	8.02	10.50	3.41	1.90	2.77	13.27	Upgrade
EV/EBITDA Ratio	222.99	385.86	-	-	-	-	Upgrade
EV/EBIT Ratio	7414.24	7414.24	-	-	-	-	Upgrade
EV/FCF Ratio	296.49	387.93	-	-	-	-	Upgrade
Debt / Equity Ratio	0.03	0.03	0.04	0.03	0.03	0.03	Upgrade
Debt / EBITDA Ratio	0.66	0.66	-	-	-	-	Upgrade
Debt / FCF Ratio	0.88	0.88	-	-	-	-	Upgrade
Asset Turnover	0.97	0.97	0.44	0.21	0.15	0.04	Upgrade
Inventory Turnover	1.18	1.18	1.27	1.47	2.33	1.96	Upgrade
Quick Ratio	1.64	1.64	2.22	2.20	2.72	7.69	Upgrade
Current Ratio	2.14	2.14	2.77	2.49	2.91	8.76	Upgrade
Return on Equity (ROE)	-6.44%	-6.44%	-16.18%	-20.02%	-9.33%	-14.18%	Upgrade
Return on Assets (ROA)	0.09%	0.09%	-4.12%	-7.06%	-5.90%	-8.09%	Upgrade
Return on Capital (ROIC)	0.11%	0.11%	-4.90%	-8.21%	-6.59%	-8.81%	Upgrade
Return on Capital Employed (ROCE)	0.20%	0.20%	-	-	-	-	Upgrade
Earnings Yield	-0.69%	-0.53%	-10.70%	-27.17%	-11.95%	-17.39%	Upgrade
FCF Yield	0.33%	0.25%	-7.14%	-14.41%	-9.13%	-14.04%	Upgrade
Buyback Yield / Dilution	-3.76%	-1.69%	-7.91%	-3.37%	-34.86%	-53.69%	Upgrade

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.